Larimar Therapeutics stock rating reiterated at Market Outperform by Citizens
PositiveFinancial Markets

Larimar Therapeutics has received a positive stock rating from Citizens, who reiterated their 'Market Outperform' stance. This endorsement is significant as it reflects confidence in the company's potential for growth and success in the market, which could attract more investors and boost stock performance.
— Curated by the World Pulse Now AI Editorial System